The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Tzield Sanofi-Aventis Australia Pty Ltd
Product name
Tzield
Sponsor
Accepted date
Feb-2025
Active ingredients
teplizumab
Proposed indication
To delay the onset and progression of diabetes.
Application type
A (new medicine)
Publication date
Feb-2025